NEW YORK (GenomeWeb News) - NanoTherics said today that it has received a grant from Advantage West Midlands that it will use to advance its gene transfection technologies.
 
The Staffordshire, UK-based company was founded in 2007 and is based on technology developed at Keele University and the University of Florida. The company’s technology uses nanoparticles and magnetic fields in the delivery of DNA and other molecules into living cells, which could be used in gene therapy programs.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.